Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis

被引:290
作者
Camargo, M. Constanza [1 ]
Kim, Woo-Ho [2 ]
Chiaravalli, Anna Maria [3 ,4 ]
Kim, Kyoung-Mee [5 ]
Corvalan, Alejandro H. [6 ]
Matsuo, Keitaro [7 ]
Yu, Jun [8 ]
Sung, Joseph J. Y. [8 ]
Herrera-Goepfert, Roberto [9 ]
Meneses-Gonzalez, Fernando [10 ]
Kijima, Yuko [11 ]
Natsugoe, Shoji [11 ]
Liao, Linda M. [1 ]
Lissowska, Jolanta [12 ]
Kim, Sung [13 ]
Hu, Nan [1 ]
Gonzalez, Carlos A. [14 ]
Yatabe, Yashushi [15 ]
Koriyama, Chihaya [11 ]
Hewitt, Stephen M. [16 ,17 ]
Akiba, Suminori [11 ]
Gulley, Margaret L. [18 ]
Taylor, Philip R. [1 ]
Rabkin, Charles S. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20852 USA
[2] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea
[3] Osped Circolo Varese, Anat Pathol Unit, Varese, Italy
[4] Univ Insubria, Varese, Italy
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea
[6] Pontificia Univ Catolica Chile, Sch Med, Dept Hematol & Oncol, Santiago, Chile
[7] Aichi Canc Ctr, Res Inst, Div Mol Epidemiol, Nagoya, Aichi 464, Japan
[8] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[9] Natl Canc Inst, Dept Pathol, Mexico City, DF, Mexico
[10] Secretaria Salud Mexico, Direcc Gen Adjunta Epidemiol, Programa Residencia Epidemiol, Mexico City, DF, Mexico
[11] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan
[12] M Sklodowska Curie Mem Canc Ctr & Inst Oncol, Div Canc Epidemiol & Prevent, Warsaw, Poland
[13] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea
[14] Catalan Inst Oncol, Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain
[15] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan
[16] NCI, Tissue Array Res Program, Rockville, MD 20852 USA
[17] NCI, Appl Mol Pathol Lab, Pathol Lab, Rockville, MD 20852 USA
[18] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
CLINICOPATHOLOGICAL FEATURES; PROGNOSTIC-SIGNIFICANCE; EXPRESSION PROFILE; PROTEIN EXPRESSION; LYMPHOID STROMA; T-LYMPHOCYTES; CARCINOMA; INFECTION; EBV; RISK;
D O I
10.1136/gutjnl-2013-304531
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and objective About 9% of gastric carcinomas have Epstein-Barr virus (EBV) in the tumour cells, but it is unclear whether viral presence influences clinical progression. We therefore examined a large multicentre case series for the association of tumour EBV status with survival after gastric cancer diagnosis, accounting for surgical stage and other prognostic factors. Methods We combined individual-level data on 4599 gastric cancer patients diagnosed between 1976 and 2010 from 13 studies in Asia (n=8), Europe (n=3), and Latin America (n=2). EBV positivity of tumours was assessed by in situ hybridisation. Mortality HRs for EBV positivity were estimated by Cox regression models stratified by study, adjusted for distributions of sex (71% male), age (mean 58years), stage (52% tumour-node-metastasis stages III or IV), tumour histology (49% poorly differentiated, 57% Lauren intestinal-type), anatomic subsite (70% non-cardia) and year of diagnosis. Variations by study and continent were assessed using study-specific HRs for EBV positivity. Results During median 3.0years follow-up, 49% of patients died. Stage was strongly predictive of mortality, with unadjusted HRs (vs stage I) of 3.1 for stage II, 8.1 for stage III and 13.2 for stage IV. Tumour EBV positivity was 8.2% overall and inversely associated with stage (adjusted OR: 0.79 per unit change). Adjusted for stage and other confounders, EBV positivity was associated with lower mortality (HR, 0.72; 95% CI 0.61 to 0.86), with low heterogeneity among the study populations (p=0.2). The association did not significantly vary across patient or tumour characteristics. There was no significant variation among the three continent-specific HRs (p=0.4). Conclusions Our findings suggest that tumour EBV positivity is an additional prognostic indicator in gastric cancer. Further studies are warranted to identify the mechanisms underlying this protective association.
引用
收藏
页码:236 / 243
页数:8
相关论文
共 64 条
[1]   Epstein-Barr virus associated gastric carcinoma: Epidemiological and clinicopathological features [J].
Akiba, Suminori ;
Koriyama, Chihaya ;
Herrera-Goepfert, Roberto ;
Eizuru, Yoshito .
CANCER SCIENCE, 2008, 99 (02) :195-201
[2]  
[Anonymous], 1998, GASTRIC CANCER, DOI DOI 10.1007/PL00011681
[3]   Parametric model to analyse the survival of gastric cancer in the presence of interval censoring [J].
Baghestani, Ahmad Reza ;
Hajizadeh, Ebrahim ;
Fatemi, Seyed Reza .
TUMORI JOURNAL, 2010, 96 (03) :433-437
[4]   Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis [J].
Camargo, M. C. ;
Murphy, G. ;
Koriyama, C. ;
Pfeiffer, R. M. ;
Kim, W. H. ;
Herrera-Goepfert, R. ;
Corvalan, A. H. ;
Carrascal, E. ;
Abdirad, A. ;
Anwar, M. ;
Hao, Z. ;
Kattoor, J. ;
Yoshiwara-Wakabayashi, E. ;
Eizuru, Y. ;
Rabkin, C. S. ;
Akiba, S. .
BRITISH JOURNAL OF CANCER, 2011, 105 (01) :38-43
[5]  
Cammerer G, 2012, ANTICANCER RES, V32, P1839
[6]   Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea [J].
Chang, MS ;
Lee, HS ;
Kim, CW ;
Kim, YI ;
Kim, WH .
PATHOLOGY RESEARCH AND PRACTICE, 2001, 197 (06) :395-400
[7]   Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection [J].
Chiaravalli, AM ;
Feltri, M ;
Bertolini, V ;
Bagnoli, E ;
Furlan, D ;
Cerutti, R ;
Novario, R ;
Capella, C .
VIRCHOWS ARCHIV, 2006, 448 (03) :344-353
[8]   Histotype-based prognostic classification of gastric cancer [J].
Chiaravalli, Anna Maria ;
Klersy, Catherine ;
Vanoli, Alessandro ;
Ferretti, Andrea ;
Capella, Carlo ;
Solcia, Enrico .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (09) :896-904
[9]  
Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6<871::AID-IJC6>3.0.CO
[10]  
2-#